{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:54:17Z","timestamp":1792180457387,"version":"4.4.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03447-6","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T16:02:52Z","timestamp":1729612972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Decoding the variability in clinical and laboratory profiles of Chronic Inducible Urticaria vs. Chronic Spontaneous Urticaria - a retrospective study from a tertiary care center"],"prefix":"10.1007","volume":"316","author":[{"given":"Muthu Sendhil","family":"Kumaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhdeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitaishi","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davinder","family":"Parsad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"issue":"3","key":"3447_CR1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/all.15090","volume":"77","author":"T Zuberbier","year":"2022","unstructured":"Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D et al (2022) The international EAACI\/GA\u00b2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 77(3):734\u2013766","journal-title":"Allergy"},{"key":"3447_CR2","doi-asserted-by":"crossref","unstructured":"Hawro T, Ohanyan T, Schoepke N, Metz M, Peveling-Oberhag A, Staubach P, Maurer M, Weller K (2018 Jul-Aug) The Urticaria Activity Score-Validity, reliability, and responsiveness. J Allergy Clin Immunol Pract 6(4):1185\u20131190e1","DOI":"10.1016\/j.jaip.2017.10.001"},{"issue":"3","key":"3447_CR3","first-page":"141","volume":"29","author":"I Pozderac","year":"2020","unstructured":"Pozderac I, Lugovi\u0107-Mihi\u0107 L, Artukovi\u0107 M, Stipi\u0107-Markovi\u0107 A, Kuna M, Fer\u010dek I (2020) Chronic inducible urticaria: classification and prominent features of physical and non-physical types. Acta Dermatovenerol Alp Pannonica Adriat 29(3):141\u2013148","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"6","key":"3447_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1684\/ejd.2019.3674","volume":"29","author":"L Curto-Barredo","year":"2019","unstructured":"Curto-Barredo L, Pujol RM, Roura-Vives G, Gimenez-Arnau AM (2019) Chronic urticaria phenotypes: clinical differences regarding triggers, activity, prognosis and therapeutic response. Eur J Dermatol 29(6):627\u2013635","journal-title":"Eur J Dermatol"},{"issue":"1","key":"3447_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/bjd.19425","volume":"184","author":"V Exposito-Serrano","year":"2021","unstructured":"Exposito-Serrano V, Curto-Barredo L, Aguilera Peiro P, Gomez Armayones S, Serra-Baldrich E, Spertino J et al (2021) Omalizumab for the treatment of chronic inducible urticaria in 80 patients. Br J Dermatol 184(1):167\u2013168","journal-title":"Br J Dermatol"},{"issue":"3","key":"3447_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/jdv.19637","volume":"38","author":"S Ornek Ozdemir","year":"2024","unstructured":"Ornek Ozdemir S, Kuteyla Can P, Degirmentepe EN, Cure K, Singer R, Kocaturk E (2024) A comparative analysis of chronic inducible urticaria in 423 patients: clinical and laboratory features and comorbid conditions. J Eur Acad Dermatol Venereol 38(3):513\u2013520","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"3447_CR7","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1111\/jdv.13765","volume":"30","author":"S Altrichter","year":"2016","unstructured":"Altrichter S, Koch K, Church MK, Maurer M (2016) Atopic predisposition in cholinergic urticaria patients and its implications. J Eur Acad Dermatol Venereol 30(12):2060\u20132065","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3447_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1590\/abd1806-4841.20165071","volume":"91","author":"GA Dias","year":"2016","unstructured":"Dias GA, Pires GV, Valle SO, Dortas SD, J\u00fanior, Levy S, Fran\u00e7a AT, Baiardini I (2016) Impact of chronic urticaria on the quality of life of patients followed up at a university hospital. Bras Dermatol 91:754\u2013759","journal-title":"Bras Dermatol"},{"issue":"10","key":"3447_CR9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1159\/000515753","volume":"182","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang H, Du S, Yan S, Zeng J (2021) Advanced biomarkers: therapeutic and diagnostic targets in Urticaria. Int Arch Allergy Immunol 182(10):917\u2013931","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"3447_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.4103\/idoj.IDOJ_106_21","volume":"12","author":"G Dabas","year":"2021","unstructured":"Dabas G, Thakur V, Bishnoi A, Parsad D, Kumar A, Kumaran MS (2021) Causal relationship between D-Dimers and Disease Status in Chronic spontaneous urticaria and adjuvant effect of oral tranexamic acid. Indian Dermatol Online J 12(5):726\u2013730","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"3447_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jdermsci.2017.02.283","volume":"87","author":"E Kocat\u00fcrk","year":"2017","unstructured":"Kocat\u00fcrk E, Can PK, Akbas PE et al (2017) Management of chronic inducible urticaria according to the guidelines: a prospective controlled study. J Dermatol Sci 87(1):60\u201369","journal-title":"J Dermatol Sci"},{"key":"3447_CR12","doi-asserted-by":"publisher","unstructured":"Ornek Ozdemir S, Can PK, Degirmentepe EN, K\u0131z\u0131lta\u00e7 K, Singer R, Kocat\u00fcrk E (2024) Unveiling treatment response predictors in predominant subtypes of chronic Inducible Urticaria. Int Arch Allergy Immunol Published Online June 18. https:\/\/doi.org\/10.1159\/000536579","DOI":"10.1159\/000536579"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03447-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03447-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03447-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:06:46Z","timestamp":1732205206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03447-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":12,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3447"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03447-6","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to retrospective study design, a waiver has been applied from institutional ethics committee vide letter number-2024\/00386. The study strictly complies with Declaration of Helsinki. Due to its retrospective nature, study was exempted from obtaining written informed consent. All patient data in this study has been de-identified and anonymized to protect individual privacy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"703"}}